Home302440 • KRX
add
SK Bioscience Co Ltd
Nakaraang pagsara
₩39,600.00
Sakop ng araw
₩39,350.00 - ₩40,100.00
Sakop ng taon
₩35,800.00 - ₩61,900.00
Market cap
3.10T KRW
Average na Volume
88.36K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 156.85B | 73.11% |
Gastos sa pagpapatakbo | 55.79B | 47.90% |
Net na kita | -6.44B | -254.38% |
Net profit margin | -4.10 | -189.13% |
Kita sa bawat share | -80.00 | -248.15% |
EBITDA | -29.16B | -4,458.31% |
Aktuwal na % ng binabayarang buwis | 87.71% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.16T | -9.11% |
Kabuuang asset | 2.84T | 53.51% |
Kabuuang sagutin | 821.14B | 452.65% |
Kabuuang equity | 2.02T | — |
Natitirang share | 78.35M | — |
Presyo para makapag-book | 1.72 | — |
Return on assets | -5.19% | — |
Return on capital | -5.85% | — |
Cash Flow
Net change in cash
| (KRW) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -6.44B | -254.38% |
Cash mula sa mga operasyon | -12.95B | -121.06% |
Cash mula sa pag-invest | -267.82B | -50.17% |
Cash mula sa financing | 72.21B | 2,863.43% |
Net change in cash | -199.58B | -65.64% |
Malayang cash flow | -134.28B | -327.19% |
Tungkol
SK Bioscience is a South Korean biotechnology company that produces vaccines and other products and is a subsidiary of SK Chemicals. Wikipedia
CEO
Itinatag
Hul 1, 2018
Website
Mga Empleyado
1,067
